Goldman Sachs
Eli Lilly and Novo Nordisk face new competition in slimming drugs market
The duopoly of US pharmaceuticals firm Eli Lilly and Danish Novo Nordisk in the slimming drugs market is threatened.
Two firms, Viking Therapeutics and Roche, announced the development of three products and Viking's shot up 39% in one day.
Goldman Sachs estimates the market for such drugs will grow from €14 billion to €130 billion by 2030.
Greece draws 3 bln euros from 30-year bond amid huge demand
Greece drew 3 billion euros from the issue of a new 30-year bond on Wednesday, securing considerable demand for the issue that came on the back of the unexpected upgrading of the country's credit outlook to "Positive" by Standard & Poor's last Friday.
Issue of new 30-year bond
Armed by the surprise move from Standard & Poor's last Friday, upgrading Greece's outlook to "Positive," the Public Debt Management Agency is on Wednesday set to make its second major market foray for 2024, with a new 30-year bond.
- Read more about Issue of new 30-year bond
- Log in to post comments
Int’l banks do not expect change in economic policies
In their assessments on the outcome of the March 31 local elections, Deutsche Bank and Goldman Sachs argued that the government is unlikely to change its economic policies.
Deutsche Bank in a report on April 1 that it is constructive on Turkish assets following the results of the March 31 elections.
Prosecutor to investigate Kasselakis’ US firm
The Athens prosecutor's office has ordered an investigation into SYRIZA head Stefanos Kasselakis' shipping business interests in the United States after documents revealed that he has owned a company abroad.
- Read more about Prosecutor to investigate Kasselakis’ US firm
- Log in to post comments
Decisions for Piraeus Bank stake
Financial consultants UBS, Goldman Sachs and Bank of America are conducting critical consultations on the intentions of potential investors in relation to the price they are willing to pay for 27% of Piraeus Bank on behalf of bank bailout fund HFSF.
- Read more about Decisions for Piraeus Bank stake
- Log in to post comments
Central Bank net reserves may turn positive: Goldman Sachs
The Turkish Central Bank's net reserves are likely to turn positive in 2024, according to analysts at Goldman Sachs.
In a note on the Central Bank's latest rate decision, Goldman Sachs said that it expects rising foreign inflows and a narrower current account deficit to pull the rate of Turkish Lira appreciation further inside the forwards in 2024.
Kasselakis commemorates Athens Polytechnic uprising
Stefanos Kasselakis, the leader of Greece's main leftist opposition, on Friday laid a wreath at the memorial on the grounds of the former Military Police Special Interrogation Unit (EAT/ESA) to commemorate the 1973 Athens Polytechnic uprising. He was joined by a delegation from his SYRIZA party.
Central Bank to hold investor meetings
Türkiye's Central Bank has announced that it will organize "Investor Days" starting from January next year.
The first Investor Day will be held on Jan. 11, 2024, in New York, according to the bank's statement issued on Nov. 13.
- Read more about Central Bank to hold investor meetings
- Log in to post comments
Goldman Sachs anticipates more takings for Greek banks
Goldman Sachs expects Greek banks to show strong results in the third quarter of the year as well, following the trend of the second quarter, with further strengthening of net interest income, which will be supported by the 50-basis point increase in interest rates, to which it is estimated that the European Central Bank will have progressed in the specific period.